141 related articles for article (PubMed ID: 7572963)
1. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium.
Friedman SR; Jose B; Deren S; Des Jarlais DC; Neaigus A
Am J Epidemiol; 1995 Oct; 142(8):864-74. PubMed ID: 7572963
[TBL] [Abstract][Full Text] [Related]
2. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
Lima ES; Bastos FI; Telles PR; Friedman SR
Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
[TBL] [Abstract][Full Text] [Related]
3. The 1993 Okey Memorial Lecture. Cross-national studies of AIDS among injecting drug users.
Des Jarlais DC
Addiction; 1994 Apr; 89(4):383-92. PubMed ID: 8025490
[TBL] [Abstract][Full Text] [Related]
4. Introduction of HIV into drug injector networks outside AIDS epicentres.
Williams ML; Zhao Z; Bowen AM; Freeman RC; Elwood WN; Rusek R
Int J STD AIDS; 1997 Oct; 8(10):629-35. PubMed ID: 9310222
[TBL] [Abstract][Full Text] [Related]
5. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
Anthony JC; Vlahov D; Nelson KE; Cohn S; Astemborski J; Solomon L
Am J Epidemiol; 1991 Nov; 134(10):1175-89. PubMed ID: 1746528
[TBL] [Abstract][Full Text] [Related]
6. Role of drug injection in the spread of HIV in Argentina and Brazil.
Libonatti O; Lima E; Peruga A; González R; Zacarías F; Weissenbacher M
Int J STD AIDS; 1993; 4(3):135-41. PubMed ID: 8324042
[TBL] [Abstract][Full Text] [Related]
7. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
8. HIV infection among intravenous drug users: epidemiology and risk reduction.
Des Jarlais DC; Friedman SR
AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
[TBL] [Abstract][Full Text] [Related]
9. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users.
Hartgers C; van Ameijden EJ; van den Hoek JA; Coutinho RA
Public Health Rep; 1992; 107(6):675-81. PubMed ID: 1454980
[TBL] [Abstract][Full Text] [Related]
10. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of drug injection behaviors and HIV infection. National AIDS Research Consortium.
Zhuo Z; Williams M; Bell D
Int J Addict; 1994 Oct; 29(12):1499-518. PubMed ID: 7836016
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of needle-exchange programmes for prevention of HIV infection.
Hurley SF; Jolley DJ; Kaldor JM
Lancet; 1997 Jun; 349(9068):1797-800. PubMed ID: 9269214
[TBL] [Abstract][Full Text] [Related]
13. Seroconversion issues among out-of-treatment injection drug users.
Fisher DG; Fenaughty AM; Trubatch B
J Psychoactive Drugs; 1998; 30(3):299-305. PubMed ID: 9798796
[TBL] [Abstract][Full Text] [Related]
14. Differences in condom behaviors and beliefs among female drug users recruited from two cities.
Wood MM; Tortu S; Rhodes F; Deren S
Women Health; 1998; 27(1-2):137-60. PubMed ID: 9640639
[TBL] [Abstract][Full Text] [Related]
15. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities.
Buchanan D; Tooze JA; Shaw S; Kinzly M; Heimer R; Singer M
Drug Alcohol Depend; 2006 Feb; 81(3):221-9. PubMed ID: 16171952
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro.
Lima ES; Friedman SR; Bastos FI; Telles PR; Friedmann P; Ward TP; des Jarlais DC
Addiction; 1994 Jun; 89(6):689-98. PubMed ID: 8069170
[TBL] [Abstract][Full Text] [Related]
17. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study.
Nicolosi A; Leite ML; Musicco M; Molinari S; Lazzarin A
Am J Epidemiol; 1992 Feb; 135(3):225-33. PubMed ID: 1312300
[TBL] [Abstract][Full Text] [Related]
18. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and HIV seropositivity among injecting drug users in Bangkok.
Choopanya K; Vanichseni S; Des Jarlais DC; Plangsringarm K; Sonchai W; Carballo M; Friedmann P; Friedman SR
AIDS; 1991 Dec; 5(12):1509-13. PubMed ID: 1814333
[TBL] [Abstract][Full Text] [Related]
20. [HIV-1 seroprevalence in pregnant women in Libreville (Gabon)].
Mounanga M; Revangue BS
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):509-12. PubMed ID: 8228014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
